Fig. 2From: Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysisRelative change (%) of myoglobin and CK during CS treatment. CK creatine kinase, CS Cytosorb®, green dots: decrease of CK during CS treatment (= group 1), red dots: increase of CK during CS treatment (= group 2)Back to article page